Antoni Ribas

Functions as a College/University

Functions as a College/University

Engages in research, education, communication and collaboration to prevent and cure cancer

Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements.

Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products

Part of University of California, Jonsson Comprehensive Cancer Center is a multidisciplinary cancer center that integrates basic, translational, and clinical research to advance personalized cancer care across all stages of treatment. The company is based in Los Angeles, CA. The center offers comprehensive services including prevention, early detection, precision diagnostics, innovative therapies, survivorship support, and access to clinical trials. It specializes in a wide range of cancers such as breast, prostate, lung, colorectal, kidney, and sarcoma, and provides targeted treatments and immunotherapies. Research is organized into interdisciplinary programs focusing on cancer stem cell biology, immunotherapy, molecular imaging, and gene regulation. The center manages clinical trial infrastructure, supports education and training for trainees and faculty, and conducts cancer prevention and control research with community outreach. Philanthropy supports research, clinical trials, and patient services, including integrative oncology programs. The center provides language and disability access services and fosters a patient-centered environment.

Functions as a College/University

Provides cancer therapeutics through innovative apps

Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers